VIM and carcinosarcoma: The SMARCA4-deficient carcinosarcoma reported in this study is an unclassified pleomorphic sarcoma, which is immunoreactive to the stromal marker Vimentin but non-immunoreactive to the epithelial markers CK, EMA.